Spruce Biosciences Inc - fluxo de caixa trimestral (NASDAQ:SPRB) | MetaTrader

Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas

Total assets 45.21 M31.65 M21.82 M15.31 M53.02 M Total liabilities 16.39 M16.32 M8.64 M9.93 M10.51 M Total equity 28.82 M15.32 M13.18 M5.39 M42.52 M Total liabilities & shareholders' equities 45.21 M31.65 M21.82 M15.31 M53.02 M Total debt 1.75 M1.34 M943 K539 K0 Net debt -37.05 M-24.25 M-15.46 M-10.16 M-48.9 M

Notícias

Citizens reitera classificação de ações da Spruce Biosciences com perspectiva de aprovação

Spruce Biosciences encerra acordo de colaboração com Kaken Pharmaceutical

Spruce Biosciences names Dale Hooks as chief commercial officer

3 ‘Strong Buy’ Stocks to Buy Now, 2/6/2026, According to Top Analysts - TipRanks.com

Big-Pharma Partner Harbour BioMed Boosts Stake In Spruce Biosciences - Spruce Biosciences (NASDAQ:SPRB)

Biotech Stocks' Dark Winter Is Over. What That Means For Investors.

Oppenheimer inicia cobertura da Spruce Biosciences com classificação de Outperform

Oppenheimer initiates coverage on Spruce Biosciences stock with Outperform rating

This Levi Strauss Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Brunswick (NYSE:BC), Cellectis (NASDAQ:CLLS)

H.C. Wainwright retoma cobertura de ações da Spruce Biosciences com recomendação de compra

Spruce Biosciences stock rating resumed at Buy by H.C. Wainwright

Spruce Biosciences nomeia Keli Walbert para conselho de administração